StockClub

NBIO

NBIONascent Biotech, Inc.$ --
Nascent Biotech, Inc.

Nascent Biotech, Inc.

NBIO

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2024FY2025 Q2
Revenue
0M USD
YoY -
Operating Income
-0M USD
YoY +70.0%
Net Income
-0M USD
YoY +69.6%
EPS
-0$
YoY +73.2%

Revenue

$0
FY2023 Q3$0
$0
Q3
FY2023 Q4$0
$0
Q4
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$3
$3
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
Actual
$0 (-)

Net Income

$-629,390
FY2023 Q3$-2.3M
$-2.3M
Q3
FY2023 Q4$-2.8M
$-2.8M
Q4
FY2024 Q1$-540,000
$-540,000
Q1
FY2024 Q2$-1.4M
$-1.4M
Q2
FY2024 Q3$-1.6M
$-1.6M
Q3
FY2024 Q4$-2.1M
$-2.1M
Q4
FY2025 Q1$-377,390
$-377,390
Q1
FY2025 Q2$-629,390
$-629,390
Q2
Actual
+$739,610 (+54.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:$0
FY2019
$0
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$750,000
FY2021
$750,000
FY2022
Actual:$1M
FY2022
$1M
FY2023
Actual:$0
FY2023
$0
FY2024
Actual:$0
FY2024
$0

Analyst Estimates

No forecast data